Research Square (Research Square),
Год журнала:
2022,
Номер
unknown
Опубликована: Сен. 27, 2022
Abstract
Background
Lung
adenocarcinoma
(LUAD)
has
a
poor
prognosis.
Circadian
genes
such
as
TIMELESS
have
been
associated
with
several
pathologies,
including
cancer.
The
expression
of
and
the
relationship
between
TIMELESS,
infiltration
tumors
prognosis
in
LUAD
requires
further
investigation.
Methods
In
this
study,
we
investigated
its
association
survival
across
types
human
cancer
using
data
from
Cancer
Genome
Atlas
(TCGA)
Genotype-Tissue
Expression
Program.
Noncoding
RNAs
(ncRNAs)
regulating
overexpression
were
explored
expression,
correlation,
analyses.
Immune
cell
biomarkers
analyzed
different
levels.
immunophenoscores,
which
used
to
predict
response
immunotherapy,
was
evaluated.
Results
identified
potential
oncogene
LUAD.
NcRNA
analysis
showed
MIR4435-2HG/hsa-miR-1-3p
may
interact
competitive
endogenous
RNA
network
tumor
tissues.
Most
immune
cells
significantly
decreased
TCGA
tissues
high
except
for
CD4
+
T
Th2
cells.
negatively
correlated
neutrophil
biomarkers,
dendritic
(HLA-DPB1,
HLA-DQB1,
HLA-DRA,
HLA-DPA1,
CD1C)
an
immunophenoscore
that
predicted
outcomes
use
checkpoint
inhibitors.
Conclusions
These
findings
imply
ncRNAs-mediated
prognosis,
reduced
microenvironment,
Neuro-Oncology,
Год журнала:
2023,
Номер
25(11), С. 1932 - 1946
Опубликована: Июнь 16, 2023
Abstract
Glioblastoma
(GBM)
is
the
most
prevalent
malignant
primary
brain
tumor,
accounting
for
14.2%
of
all
diagnosed
tumors
and
50.1%
tumors,
median
survival
time
approximately
8
months
irrespective
whether
a
patient
receives
treatment
without
significant
improvement
despite
expansive
research
(Ostrom
QT,
Price
M,
Neff
C,
et
al.
CBTRUS
statistical
report:
other
central
nervous
system
in
United
States
2015–2019.
Neurooncology.
2022;
24(suppl
5):v1–v95.).
Recently,
important
roles
circadian
clock
GBM
tumorigenesis
have
been
reported.
Positive
regulators
circadian-controlled
transcription,
muscle
ARNT-like
1
(BMAL1),
locomotor
output
cycles
kaput
(CLOCK),
are
highly
expressed
also
correlated
with
poor
prognosis.
BMAL1
CLOCK
promote
maintenance
stem
cells
(GSCs)
establishment
pro-tumorigenic
tumor
microenvironment
(TME),
suggesting
that
targeting
core
proteins
may
augment
treatment.
Here,
we
review
findings
highlight
critical
role
plays
biology
strategies
by
which
can
be
leveraged
clinic
moving
forward.
International Journal of Molecular Sciences,
Год журнала:
2022,
Номер
23(3), С. 1331 - 1331
Опубликована: Янв. 25, 2022
Circadian
disruption
has
been
linked
to
cancer
development,
progression,
and
radiation
response.
Clinical
evidence
date
shows
that
circadian
genetic
variation
time
of
treatment
affect
response
toxicity
for
women
with
breast
cancer.
At
the
molecular
level,
there
is
interplay
between
clock
regulators
such
as
PER1,
which
mediates
ATM
p53-mediated
cell
cycle
gating
apoptosis.
These
alterations
may
govern
aggressive
phenotypes,
outcomes,
Exploiting
various
mechanisms
enhance
therapeutic
index
by
decreasing
toxicity,
increasing
disease
control,
improving
outcomes.
We
will
review
body's
natural
rhythms
gene-regulation
while
exploring
preclinical
clinical
implicates
chronobiological
disruptions
in
etiology
discuss
radiobiological
principles
regulation
DNA
damage
responses.
Lastly,
we
present
potential
rational
approaches
target
pathways
improve
outcomes
Understanding
implications
optimal
timing
ways
entrain
biology
light,
diet,
agents
like
melatonin
provide
an
avenue
enhancing
radiotherapy.
X-ray
repair
cross-complementation
group
1
(XRCC1)
is
a
pivotal
contributor
to
base
excision
repair,
and
its
dysregulation
has
been
implicated
in
the
oncogenicity
of
various
human
malignancies.
However,
comprehensive
pan-cancer
analysis
investigating
prognostic
value,
immunological
functions,
epigenetic
associations
XRCC1
remains
lacking.
To
address
this
knowledge
gap,
we
conducted
systematic
investigation
employing
bioinformatics
techniques
across
33
cancer
types.
Our
encompassed
expression
levels,
diagnostic
implications,
profiles,
immune
molecular
subtypes,
Tumor
Mutation
Burden
(TMB),
Microsatellite
Instability
(MSI),
checkpoints,
infiltration,
leveraging
data
from
TCGA,
GTEx,
CELL,
Human
Protein
Atlas,
Ualcan,
cBioPortal
databases.
Notably,
displayed
both
positive
negative
correlations
with
prognosis
different
tumors.
Epigenetic
revealed
between
DNA
methylation
patterns
10
types,
as
well
enhanced
phosphorylation.
Furthermore,
demonstrated
TMB
MSI
majority
Interestingly,
gene
exhibited
correlation
cell
infiltration
except
for
M1
M2
macrophages
monocytes
most
cancers.
Additionally,
observed
significant
checkpoint
levels.
Lastly,
our
findings
replication
processes,
shedding
light
on
precise
mechanisms
underlying
oncogenic
effects.
Overall,
study
highlights
potential
biomarker,
thereby
offering
novel
target
tumor
immunotherapy.
Cancers,
Год журнала:
2025,
Номер
17(5), С. 732 - 732
Опубликована: Фев. 21, 2025
In
the
era
of
precision
medicine,
mounting
evidence
suggests
that
time
therapy
administration,
or
chronotherapy,
has
a
great
impact
on
treatment
outcomes.
Chronotherapy
involves
planning
timing
by
considering
circadian
rhythms,
which
are
24
h
oscillations
in
behavior
and
physiology
driven
synchronized
molecular
clocks
throughout
body.
The
value
chronotherapy
cancer
is
currently
under
investigation,
notably
effects
efficacy
side
effects.
Immune
checkpoint
inhibitor
(ICI)
promising
treatment.
However,
many
patients
still
experience
disease
progression
need
to
stop
early
due
There
accumulating
day
at
ICI
administered
can
have
substantial
effect
efficacy.
Thus,
it
important
investigate
intersections
this
review,
we
provide
brief
overview
rhythms
context
immunity
cancer.
Additionally,
outline
current
applications
for
We
synthesize
29
studies
conducted
date
examine
time-of-day
administration
therapy,
its
associated
effects,
sex
differences
both
also
discuss
potential
mechanisms
underlying
these
observed
results.
Finally,
highlight
challenges
area
future
directions
research,
including
chronotherapeutic
personalized
medicine
approach
tailors
individual
patients’
rhythms.
Cancers,
Год журнала:
2025,
Номер
17(11), С. 1880 - 1880
Опубликована: Июнь 4, 2025
Background/Objectives:
Radiotherapy
is
a
cornerstone
in
the
treatment
of
breast
cancer,
yet
its
use
frequently
accompanied
by
skin
toxicities
that
vary
severity
and
timing
among
patients.
The
objective
this
meta-analysis
to
systematically
evaluate
pooled
impact
genetic
variations
on
risk
acute
late
side
effects
from
radiotherapy
cancer
Materials
Methods:
A
systematic
literature
search
was
conducted
across
PubMed,
Embase,
Scopus
identify
studies
published
between
2014
2024
examined
associations
polymorphisms
radiotherapy-induced
toxicity.
Studies
were
selected
based
predefined
inclusion
exclusion
criteria,
data
synthesized
using
random-effects
model.
bias
evaluated
ROBINS-I
tool,
publication
assessed
through
funnel
plots
Egger’s
test.
Results:
total
11
involving
patients
included,
identifying
various
gene
analysis
revealed
with
specific
variants
had
53%
increased
44%
effects.
Notable
implicated
genes
included
XRCC2,
IFNG,
ATM,
TGFB1,
PER3.
Significant
heterogeneity
noted
studies,
warranting
cautious
interpretation.
Conclusions:
This
highlights
role
variation
predicting
toxicity
These
findings
support
future
development
predictive
biomarkers
personalized
strategies
minimize
treatment-related
Pharmaceutics,
Год журнала:
2023,
Номер
15(8), С. 2023 - 2023
Опубликована: Июль 26, 2023
Circadian
rhythms
are
internal
manifestations
of
the
24-h
solar
day
that
allow
for
synchronization
biological
and
behavioral
processes
to
external
day.
This
precise
regulation
physiology
behavior
improves
adaptive
function
survival.
Chronotherapy
takes
advantage
circadian
in
physiological
optimize
timing
drug
administration
achieve
maximal
therapeutic
efficacy
minimize
negative
side
effects.
cancer
treatment
was
first
demonstrated
be
beneficial
more
than
five
decades
ago
has
favorable
effects
across
diverse
types.
However,
implementation
chronotherapy
clinic
remains
limited.
The
present
review
examines
evidence
chronotherapeutic
solid
tumors.
Specifically,
studies
examining
chrono-chemotherapy,
chrono-radiotherapy,
alternative
chronotherapeutics
(e.g.,
hormone
therapy,
TKIs,
antiangiogenic
immunotherapy)
discussed.
In
addition,
we
propose
areas
needed
research
identify
challenges
field
remain
addressed.
Background:
The
circadian
system,
a
vital
temporal
regulator
influencing
physiological
processes,
has
implications
for
cancer
development
and
treatment
response.
Our
study
assesses
timing's
impact
on
whole-brain
radiotherapy
outcomes
in
brain
metastases
personalized
therapy
insights.
Aim:
Evaluate
influence
radiation
timing
its
correlation
with
clinical
outcomes.
Identify
patient
populations
benefiting
from
interventions
synchronizing
rhythms,
considering
subgroup
differences
potential
disparities
related
to
social
determinants
of
health
(SDoH).
Design:
IRB-approved
retrospective
analysis
237
patients
undergoing
(2017–2021),
receiving
over
80%
treatments
the
morning
or
afternoon.
Survival
analyses
utilized
Kaplan–Meier
curves.
Setting/Participants:
Single-institution
involving
radiotherapy.
Collected
demographic,
disease,
socioeconomic
parameters
electronic
medical
records.
Results:
Morning
(n=158)
showed
trend
towards
improved
overall
survival
vs.
afternoon
(n=79),
median
158
79
days
(p=0.20,
HR=0.84,
CI95%
0.84–0.91).
Subgroup
benefits
females
(p=0.04)
trends
controlled
primary
disease
(p=0.11)
breast
(p=0.08).
SDoH-based
observed,
Black
lower-income
exhibiting
diminished
influence.
Conclusions:
Emphasizes
chronobiological
factors'
relevance
therapy.
correlates
survival,
particularly
specific
subgroups.
Identifies
based
SDoH,
laying
foundation
rhythms
enhanced
efficacy.
Frontiers in Oncology,
Год журнала:
2022,
Номер
12
Опубликована: Март 9, 2022
The
circadian
system
is
an
innate
clock
mechanism
that
governs
biological
processes
on
a
near
24-hour
cycle.
Circadian
rhythm
disruption
(i.e.,
misalignment
of
rhythms),
which
results
from
the
lack
synchrony
between
master
located
in
suprachiasmatic
nuclei
(SCN)
and
environment
exposure
to
day
light)
or
peripheral
clocks,
has
been
associated
with
increased
risk
unfavorable
cancer
outcomes.
Growing
evidence
supports
link
prevalence
mortality
genitourinary
cancers
(GU)
including
prostate,
bladder,
renal
cancer.
also
plays
essential
role
timely
implementation
chronopharmacological
treatments,
such
as
melatonin
chronotherapy,
reduce
tumor
progression,
improve
therapeutic
response
negative
therapy
side
effects.
potential
benefits
manipulating
rhythms
clinical
setting
GU
detection
treatment
remain
be
exploited.
In
this
review,
we
discuss
current
influence
(disease)
development
hope
elucidate
unmet
need
defining
extensive
involvement
predicting
for
alleviating
burden
implementing
anti-cancer
therapies.